Understanding Chinese Pharmacopoeia (ChP) 2020
标签:China Pharmaceutical, Pharmaceutical • 2022年6月1日 • 0 条评论
Background The Pharmacopoeia of the People’s Republic of China (Chinese Pharmacopoeia, or ChP) is China’s official collection of standards…
标签:China Pharmaceutical, Pharmaceutical • 2022年6月1日 • 0 条评论
Background The Pharmacopoeia of the People’s Republic of China (Chinese Pharmacopoeia, or ChP) is China’s official collection of standards…
标签:China Cosmetics, China Pharmaceutical, Pharmaceutical • 2022年5月30日 • 0 条评论
As more sodium hyaluronate products emerge on the market, China is going to update its regulations to better guide the registration and supervision of…
标签:China Pharmaceutical, Pharmaceutical • 2022年5月20日 • 0 条评论
In recent years, China’s pharmaceutical industry has been developing, reforming, and innovating. As a highlight in China’s Drug Administra…
标签:China Pharmaceutical, Pharmaceutical • 2022年5月20日 • 0 条评论
On May 9, China National Medical Products Administration (NMPA) released the draft of the revised Regulations for Implementation of the Drug Administr…
标签:China Pharmaceutical, drug registration • 2022年4月20日 • 0 条评论
Background China’s over-the-counter (OTC) drug market is enormous, with the size of 109.22 billion yuan (circa US$17.13 billion) in 2020. The ma…
标签:China Pharmaceutical, drug registration, Pharmaceutical • 2022年4月8日 • 0 条评论
China NMPA Releases the 52nd List of RLDs On March 11, China NMPA released the 52nd List of Reference Listed Drugs (RLDs). The list covers 52 drugs, i…